Pan-Cancer Liquid Biopsy Assay for Mutation Profiling in 61 Genes by Low-Depth Sequencing

被引:0
|
作者
Hao, P. [1 ]
Zhang, D. [1 ]
Khodaverdian, V. [1 ]
Dai, P. [1 ]
机构
[1] Nuprobe, Houston, TX USA
来源
JOURNAL OF MOLECULAR DIAGNOSTICS | 2020年 / 22卷 / 11期
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
ST75
引用
收藏
页码:S81 / S81
页数:1
相关论文
共 50 条
  • [41] Analytical Validation of a 33-Gene Pan-Cancer Circulating Tumor DNA-Based Next-Generation Sequencing Assay
    Schneider, A.
    Campion, M.
    Hofich, C.
    Milosevic, D.
    Voss, J.
    Pitel, B.
    Tillmans, L.
    Ward, A.
    Peterson, L.
    Stier, T.
    Swank, J.
    Peng, J.
    Halling, K.
    Kipp, B.
    Niu, Z.
    Zheng, G.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2022, 24 (10): : S141 - S141
  • [42] Whole exome sequencing for determination of tumor mutation load in liquid biopsy from advanced cancer patients
    Koeppel, Florence
    Blanchard, Steven
    Jovelet, Cecile
    Genin, Berengsre
    Marcaillou, Charles
    Martin, Emmanuel
    Rouleau, Etienne
    Solary, Eric
    Soria, Jean-Charles
    Andre, Fabrice
    Lacroix, Ludovic
    PLOS ONE, 2017, 12 (11):
  • [43] Comprehensive genomic profiling of SMARCA2/4 alterations in Chinese pan-cancer patients (pts) identified by next generation sequencing (NGS)
    Liu, J.
    Li, S.
    Gao, T.
    Wang, C.
    He, Q.
    Wang, D.
    Ma, T.
    ANNALS OF ONCOLOGY, 2021, 32 : S1241 - S1242
  • [44] Multi Institutional Evaluation of a High Sensitive NGS Assay for Liquid Biopsy Mutation Detection in Lung Cancer
    Vollbrecht, C.
    Costa, J. L.
    Weren, R.
    Rachiglio, A. M.
    Mafficini, A.
    Kurth, H.
    Reiman, A.
    Didelot, A.
    Boag, A.
    Nishino, K.
    Feilotter, H. E.
    Laurent-Puig, P.
    Sheils, O.
    Scarpa, A.
    Ligtenberg, M.
    Cree, I. A.
    Machado, J. C.
    Normanno, N.
    Hummel, M.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (02): : S51 - S52
  • [45] Ancestry-associated differences in somatic mutation rates from tumor profiling data of a pan-cancer cohort of 100,000 patients
    Rhead, Brooke
    Pouliot, Yannick
    Guinney, Justin
    de la Vega, Francisco M.
    CANCER RESEARCH, 2023, 83 (07)
  • [46] Analytic and Clinical Validation of a Pan-Cancer NGS Liquid Biopsy Test for the Detection of Copy Number Amplifications, Fusions and Exon Skipping Variants
    Audetat, Audrey
    Tschida, Cherie
    Kreston, Sarah
    Stephen, Adam
    D'Alessio, Brittany
    Bondy, Madeline
    Jackson, Leisa
    Mellert, Hestia
    Givens, Niki
    Sathyanarayana, Ubaradka G.
    Pestano, Gary A.
    DIAGNOSTICS, 2022, 12 (03)
  • [47] Serial changes in liquid biopsy-derived variant allele frequency predict immune checkpoint inhibitor responsiveness in the pan-cancer setting
    Kato, Shumei
    Li, Bing
    Adashek, Jacob J.
    Cha, Seong Won
    Bianchi-Frias, Daniella
    Qian, Dajun
    Kim, Lisa
    So, Tiffany W.
    Mitchell, Marcus
    Kamei, Naoki
    Hoiness, Robert
    Hoo, Jayne
    Gray, Phillip N.
    Iyama, Teruaki
    Kashiwagi, Masahide
    Lu, Hsiao-Mei
    Kurzrock, Razelle
    ONCOIMMUNOLOGY, 2022, 11 (01):
  • [48] Pan-cancer analysis identifies migrasome-related genes as a potential immunotherapeutic target: A bulk omics research and single cell sequencing validation
    Qin, Yan
    Yang, Jie
    Liang, Cao
    Liu, Jun
    Deng, Zhixing
    Yan, Binli
    Fu, Ying
    Luo, Yinghua
    Li, Xiaozhen
    Wei, Xiaoying
    Li, Wei
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [49] The mutation in splicing factor genes correlates with unfavorable prognosis, genomic instability, anti-tumor immunosuppression and increased immunotherapy response in pan-cancer
    Luo, Jiangti
    Chen, Canping
    Liu, Zhixian
    Wang, Xiaosheng
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 10
  • [50] Pan-cancer analysis of tumor mutation burden sensitive tumors reveals tumor-specific subtypes and hub genes related to immune infiltration
    Wu, Huan
    Wang, Hanchu
    Chen, Yue
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (07) : 2793 - 2804